We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02520011
Brief Title: Alvocidib Biomarker-driven Phase 2 AML Study

First Submitted : August 6, 2015
First Submitted that Met QC Criteria : August 6, 2015
First Posted : August 11, 2015 (Estimate)

Last Update Submitted : January 11, 2018
Last Update Submitted that Met QC Criteria : January 11, 2018
Last Update Posted : January 15, 2018 (Estimate)